Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Nasdaq

Walgreens Stock Fell 8% This Week: What Happened?

Walgreens Boots Alliance Inc (NASDAQ: WBA) shares continue to trade lower Friday after the company on Thursday reported financial results and reaffirmed soft guidance for low-single digit earnings growth.

Benzinga

Why Duck Creek Share Are Plunging Today

Analysts slashed their price targets on Duck Creek Technologies Inc (NASDAQ: DCT)

Benzinga

Check Out What Whales Are Doing With TTD

A whale with a lot of money to spend has taken a noticeably bearish stance on Trade Desk. Looking at options history for Trade Desk (NASDAQ:TTD) we detected 20 strange trades.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Peering Into Broadcom Inc's Recent Short Interest

Broadcom Inc's (NASDAQ:AVGO) short percent of float has risen 15.38% since its last report. The company recently reported that it has 5.39 million shares sold short, which is 1.35% of all regular shares that are available for trading.

Benzinga

Preferred Bank: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Preferred Bank (NASDAQ:PFBC).

Benzinga

Village Super Market: Dividend Insights

Tuesday marks the last chance for investors to receive the next dividend payout from Village Super Market (NASDAQ:VLGEA).

Benzinga

Tuesday Is Your Last Chance To Buy Ingles Markets Before The Dividend Payout

Tuesday marks the last chance for investors to receive the next dividend payout from Ingles Markets (NASDAQ:IMKTA).

Benzinga

Read news from The Economist, FT, and more,
with one subscription

5 Value Stocks To Watch In The Consumer Defensive Sector

What Defines a Value Stock?

Benzinga

Overview Of Value Stocks In The Basic Materials Sector

Understanding Value Stocks

Benzinga

This Bitcoin Mining Startup Looks To Go Public Via SPAC Merger Worth $1.3B

Bitcoin mining and infrastructure startup Prime Blockchain Inc agreed to go public in the U.S. via a special purpose acquisition company (SPAC) merger with 10X Capital Venture Acquisition Corp II (NASDAQ:VCXA). The deal is worth $1.25 billion, including debt. Prime Blockchain operated data centers and crypto mining operations across North America. Former Goldman Sachs Group Inc (NYSE:GS)…

Benzinga

T2 Biosystems Secures Additional BARDA Funding To Develop Blood Test Panels To Detect Sepsis-Causing Pathogens

The Biomedical Advanced Research and Development Authority (BARDA) is providing an additional $4.4 million in funding for the multiple-year cost-share contract between BARDA and T2 Biosystems Inc (NASDAQ:TTOO) If all contract options are exercised, the total potential BARDA funding is $69.0 million. The additional funding will be used to advance the U.S. clinical trials for…

Benzinga

Here's Why SG Blocks Shares Are Rising

SG Blocks Inc (NASDAQ: SGBX) shares are trading higher by 20.2% at $2.34 after the company announced SG ECHO, a subsidiary of SG Blocks, has broadened its relationship with a private client which is producing the company’s largest contract to date with SG ECHO.

Benzinga

LGVN: LGVN Publishes Positive Alzheimer's Results

By Brad Sorensen, CFA NASDAQ:LGVN READ THE FULL LGVN RESEARCH REPORT

Benzinga

Mid-Morning Market Update: Markets Higher; US Economy Adds 431,000 Jobs In March

U.S. stocks opened higher this morning following the release of non-farm payroll data for March.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Expert Ratings For Centennial Resource Dev

Over the past 3 months, 6 analysts have published their opinion on Centennial Resource Dev (NASDAQ:CDEV) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga

Looking Into Netflix Inc's Recent Short Interest

Netflix Inc's (NASDAQ:NFLX) short percent of float has fallen 6.44% since its last report. The company recently reported that it has 10.80 million shares sold short, which is 2.47% of all regular shares that are available for trading.

Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For April 1, 2022

Upgrades

Benzinga

Earnings Preview: Social Reality

Social Reality (NASDAQ:SRAX) is set to give its latest quarterly earnings report on Monday, 2022-04-04. Here's what investors need to know before the announcement. Analysts estimate that Social Reality will report an earnings per share (EPS) of $2.56.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Meridian Bioscience Earnings Perspective: Return On Capital Employed

According to Benzinga Pro, during Q1, Meridian Bioscience (NASDAQ:VIVO) earned $15.34 million, a 130.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $88.34 million in sales, a 15.93% increase since Q4.

Benzinga

Hycroft Mining Holding's Return On Capital Employed Overview

Benzinga Pro data, Hycroft Mining Holding (NASDAQ:HYMC) reported Q4 sales of $24.02 million. Earnings fell to a loss of $47.24 million, resulting in a 103.49% decrease from last quarter.

Benzinga

Verb Tech Earnings Perspective: Return On Capital Employed

According to Benzinga Pro data, during Q4, Verb Tech (NASDAQ:VERB) posted sales of $2.71 million. Earnings were up 37.26%, but Verb Tech still reported an overall loss of $5.52 million.

Benzinga

Looking Into AgileThought's Return On Invested Capital

According to Benzinga Pro data, during Q4, AgileThought (NASDAQ:AGIL) posted sales of $42.09 million. Earnings were up 44.62%, but AgileThought still reported an overall loss of $5.97 million.

Benzinga

Aravive Earnings Perspective: Return On Capital Employed

Aravive (NASDAQ:ARAV) brought in sales totaling $985.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 16.87%, resulting in a loss of $12.96 million.

Benzinga

Inhibikase Therapeutics's Return On Capital Employed Overview

Inhibikase Therapeutics (NASDAQ:IKT) brought in sales totaling $1.94 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 12.76%, resulting in a loss of $5.04 million.

Benzinga

Finch Therapeutics Group Earnings Perspective: Return On Capital Employed

Finch Therapeutics Group (NASDAQ:FNCH) brought in sales totaling $806.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 91.41%, resulting in a loss of $19.05 million.

1 … 787 788 789 790

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.